Nextech Invest, Ltd.

CIK

1595430

Location

Zurich, V8

Portfolio Value

Mid $2,099,516,941

Diversification

Highly concentrated

Filing Date

Global Rank

#1,538 / 8,793 ▲ 148 · as of Jun 2026

Top Industry

Biotechnology 100.0%

3Y Alpha vs SPY

+163.2%

Period ended 3 months ago

Filed Aug 14, 2026 · 49d

6 quarters · since Mar 2025

Clone Performance

Build a hypothetical price-return history from this filer's public 13F holdings.

View clone backtest

Portfolio Concentration

15 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

67.8%

+15.8 pts

Top 5

90.1%

+4.6 pts

Top 10

98.3%

+2.5 pts

HHI

4,742

Highly concentrated+1,703

Portfolio Trend

6 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	100.0%	$2,099,516,941	15

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

3 positions

Ticker	Company	Δ Shares	Shares	Value
RLAY	Relay Therapeutics, Inc.	+1,250,000	6,776,506	$126,788,427
ARVN	Arvinas, Inc.	+583,319	1,122,713	$9,329,745
GLUE	Monte Rosa Therapeutics, Inc.	+456,916	761,153	$18,419,902
No positions match the current search.

Trimmed

Positions the filer reduced

1 positions

Ticker	Company	Δ Shares	Shares	Value	Open
TYRA	Tyra Biosciences, Inc.	−502,276	3,553,585	$113,501,504
No positions match the current search.

New Positions

Positions the filer opened this quarter

1 positions

Ticker	Company	Shares	Value	Open
PBLS	Parabilis Medicines, Inc.	4,663,176	$127,631,127
No positions match the current search.

Sold Out

Positions the filer fully exited

3 positions

Ticker	Company	Shares	Value
TNGX	Tango Therapeutics, Inc.	7,266,081	$152,006,414
CGEM	Cullinan Therapeutics, Inc.	1,141,145	$16,215,670
SPRY	ARS Pharmaceuticals, Inc.	610,703	$4,903,945
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

15 tracked positions · $2,099,516,941 total · filing declares 16 positions · $2,107,306,424 · as of Jun 30, 2026

All sectors Healthcare

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
RVMD	Revolution Medicines, Inc. Healthcare	Held	7,601,087	0	$1,423,531,573	+92.6%	67.80%
PBLS	Parabilis Medicines, Inc. Healthcare	NEW	4,663,176	NEW	$127,631,127	NEW	6.08%
RLAY	Relay Therapeutics, Inc. Healthcare	Added	6,776,506	+1,250,000	$126,788,427	+130.6%	6.04%
TYRA	Tyra Biosciences, Inc. Healthcare	Reduced	3,553,585	-502,276	$113,501,504	−26.9%	5.41%
ALMS	Alumis Inc. Healthcare	Held	3,540,998	0	$99,643,683	+27.7%	4.75%
ORIC	Oric Pharmaceuticals, Inc. Healthcare	Held	7,162,637	0	$77,571,358	−14.5%	3.69%
KYMR	Kymera Therapeutics, Inc. Healthcare	Held	278,896	0	$31,981,004	+37.7%	1.52%
ZYME	Zymeworks Inc. Healthcare	Held	1,113,946	0	$29,118,548	+4.4%	1.39%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	Added	761,153	+456,916	$18,419,902	+268.1%	0.88%
CTMX	CytomX Therapeutics, Inc. Healthcare	Held	4,449,932	0	$16,687,245	−20.2%	0.79%
SLN	Silence Therapeutics plc Healthcare	Held	952,400	0	$10,457,352	+108.3%	0.50%
ARVN	Arvinas, Inc. Healthcare	Added	1,122,713	+583,319	$9,329,745	+63.2%	0.44%
CRVS	Corvus Pharmaceuticals, Inc. Healthcare	Held	450,000	0	$6,723,000	+2.1%	0.32%
CNTX	Context Therapeutics Inc. Healthcare	Held	7,419,355	0	$4,110,322	−78.9%	0.20%
ENGN	enGene Therapeutics Inc. Healthcare	Held	2,324,943	0	$4,022,151	−74.6%	0.19%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.